Latest Period
n/a
Security Snapshot
Scilex Holding Co - Common Stock par value $0.0001 per share (SCLX) Institutional Ownership
CUSIP: 80880W106
13F Institutional Holders and Ownership History from Q4 2022 to Q4 2025
Institutions Reporting
Shares (Excl. Options)
Price
$0.20
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock par value $0.0001 per share
- Symbol
- SCLX on Nasdaq
- Shares outstanding
- 7,401,182
- SEC-reported price per share
- $0.20
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SCLX - Scilex Holding Co - Common Stock par value $0.0001 per share is tracked under CUSIP 80880W106.
- Latest finished 13F holder period is not available.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 0 to 0 between Q3 2025 and Q4 2025.
- SEC-reported value moved from $0 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
80880W106
Latest holder period
n/a
13F holders
13D/G owners
2
CIK / CUSIP context first
SCLX full holder history
Scilex Holding Co SEC filings
Scilex Holding Co company facts
Scilex Holding Co insider transactions
Scilex Holding Co 13D/G history
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 80880W106:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
SCLX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SCLX Stock Acquisition JV LLC | 21% | -7.4% | $16,117,386 | -$805,874 | 80,586,928 | -4.8% | SCLX Stock Acquisition JV LLC | 21 Jan 2025 |
| ORAMED PHARMACEUTICALS INC. | 9.9% | +62% | $146,543 | -$2,953,457 | 732,717 | -95% | Oramed Pharmaceuticals Inc. | 31 Mar 2025 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
13
Latest
n/a
Rows shown
1-13 of 13
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 0 | $0 | -$180,727 | $0.20 | 0 |
| 2025 Q3 | 0 | $0 | -$1,245 | $0.20 | 0 |
| 2025 Q2 | 3,046 | $1,000 | -$11,031,952 | $0.33 | 1 |
| 2025 Q1 | 44,423,704 | $11,038,255 | -$1,419,016 | $0.25 | 75 |
| 2024 Q4 | 49,074,470 | $20,921,334 | +$6,258,681 | $0.43 | 95 |
| 2024 Q3 | 34,160,004 | $31,583,003 | -$5,639,463 | $0.92 | 90 |
| 2024 Q2 | 39,828,625 | $76,861,242 | +$22,125,681 | $1.93 | 85 |
| 2024 Q1 | 28,595,225 | $45,465,908 | +$3,744,037 | $1.59 | 89 |
| 2023 Q4 | 26,162,251 | $53,367,500 | -$5,912,027 | $2.04 | 89 |
| 2023 Q3 | 29,057,166 | $40,677,277 | +$8,165,747 | $1.40 | 77 |
| 2023 Q2 | 21,484,428 | $119,656,295 | +$48,670,189 | $5.57 | 88 |
| 2023 Q1 | 12,711,330 | $104,208,705 | +$103,820,839 | $8.20 | 83 |
| 2022 Q4 | 53,004 | $240,143 | +$240,143 | $3.99 | 7 |